Morgan Stanley Maintains Equal-Weight on Exelixis, Lowers Price Target to $57

Benzinga · 19h ago
Morgan Stanley analyst Sean Laaman maintains Exelixis (NASDAQ:EXEL) with a Equal-Weight and lowers the price target from $60 to $57.